FORM OF EXECUTIVE AGREEMENTExecutive Agreement • July 28th, 2011 • Human Genome Sciences Inc • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledJuly 28th, 2011 Company Industry JurisdictionThis EXECUTIVE AGREEMENT (the “Agreement”) is made and entered into as of the day of , 20 (the “Effective Date”), by and between HUMAN GENOME SCIENCES, INC. (the “Company”), and (“Executive”).
THIRD AMENDMENT TO THE EMPLOYMENT AGREEMENT BY AND BETWEEN HUMAN GENOME SCIENCES, INC. AND H. THOMAS WATKINSEmployment Agreement • July 28th, 2011 • Human Genome Sciences Inc • Biological products, (no disgnostic substances)
Contract Type FiledJuly 28th, 2011 Company IndustryWHEREAS, HUMAN GENOME SCIENCES, INC. (the “Company”) and H. THOMAS WATKINS (“Executive”) have entered into an employment agreement, dated as of November 21, 2004, as amended by the first and second amendments thereto (the “Employment Agreement”) and a letter agreement, dated December 18, 2007 under which the Executive participates in the Company’s Second Amended and Restated Key Executive Severance Plan (the “KESP Participation Letter”);